FARMACOGENOMICA

cun id: 
744

INVESTIGATION OF GENETICALLY DETERMINED HYPOCHOLESTEROLEMIC SYNDROMES TO EVALUATE THE RISK OF HEPATIC COMPLICATIONS RELATED TO THE USE OF NEW CHOLESTEROL-LOWERING DRUGS: EVIDENCE FROM FAMILY AND MENDELIAN RANDOMIZATION STUDIES.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma